At baseline for the two groups combined, mean age was 48 years
#Pharmacology #Gastroenterology #Medicine #ClinicalPharmacology #PPIs #GERD #PepticUlcer #MedicalEducation #Healthcare #DrugMechanism #EvidenceBasedMedicine To view or add a comment, sign in Here it is our major consensus statements regarding fatty liver (#MASLD), published previously
2021;13(11):e20041
GLP-1 therapy may be appropriate for adults who: Have struggled with weight despite lifestyle changes Experience frequent hunger or cravings Have insulin resistance or blood sugar concerns Want physician-guided care rather than online-only programs A medical evaluation is always required, and GLP-1 therapy is not appropriate for everyone
00:15:24 Vickie Danaher So when you put all that together, the goal isnt to say that one medication is universally better, but to help match the option to each patients preferences, routine, risk factors, and values
Gentle enough for newborns, safe for daily use, and tested by both pediatricians and dermatologists